What is the Latest Update on the Lipitor Diabetes Litigation?
While a growing number of cases are being pursued by individuals throughout the United States who allege that they suffered diabetes side effects from Lipitor, the litigation remains in the very early stages.
As of early-2014, several hundred lawsuits have been filed in state and federal courts nationwide. However, it is expected that thousands of cases will ultimately be included in the Lipitor litigation as more complaints are filed by women diagnosed with type 2 diabetes after using Lipitor.
Learn More About the Lipitor Diabetes Litigation
Millions of users of the blockbuster cholesterol drug are just now learning about the connection between Lipitor and diabetes in women, although information suggests that Pfizer knew or should have known about the risk for years.
Lipitor (atorvastatin) was first introduced in 1996 and generated more than $125 billion in sales for Pfizer before it became available as a generic in 2011.
It is one of the best known brand-name prescription medications in the world and thousands of former users may have developed type 2 diabetes as a result of the cholesterol drug.
A diabetes diagnosis from Lipitor can have a substantial impact on an individual’s overall health and quality of life, resulting in permanent lifestyle changes and increasing the risk of a number of other health problems, including the heart disease the drug was supposed to help prevent.
According to allegations raised in the Lipitor diabetes litigation, Pfizer should be required to compensate users for failing to disclose information about the potential side effects of their medication.
If proper warnings had been provided for consumers and the medical community, thousands of women may have avoided this devastating disease by choosing not to use Lipitor or by monitoring their blood glucose levels to see if the drug was adversely affecting their metabolism.
2014 Lipitor Diabetes Litigation Status
In February 2014, the U.S. Judicial Panel on Multidistrict Litigation (JPML) approved a request to consolidate and centralize all Lipitor diabetes cases pending throughout the federal court system, placing the litigation before U.S. District Judge Richard M. Gergel in the District of South Carolina to reduce duplicative discovery, avoid conflicting pretrial rulings from different judges and to serve the convenience of the parties, witnesses and the courts.
While an MDL is often confused with a Lipitor class action lawsuit, each claim would still remain an individual case. The litigation will not proceed through one class representative, but each plaintiff must still establish that their specific diabetes diagnosis was caused by Lipitor and that Pfizer provided inadequate warnings.
Throughout the remainder of 2014, the status of the Lipitor litigation is unlikely to change substantially, as the earliest cases continue to be filed and the organizational structure of the MDL proceedings are established. In 2014 and the first part of 2015, it is expected that cases will likely proceed through general and case-specific discovery in preparation for any early test trials, commonly referred to as “bellwether” cases.
Unforunately, the litigation process is a lengthy one and it is unlikely that any cases will reach a jury for several years. However, if Pfizer does not ultimately agree to settle Lipitor diabetes cases, they could face thousands of separate trials in courts throughout the country.
Join the Litigation Over Lipitor
If you, a friend or family member has been diagnosed with diabetes that may have been caused by the cholesterol drug Lipitor, it is not too late to join the litigation for Lipitor. The lawyers at Saiontz & Kirk, P.A. are continuing to review potential new cases throughout the United States for women diagnosed with diabetes from Lipitor.
All cases are pursued by our law firm under a contingency fee agreement, which means that there are no Lipitor attorney fees unless a recovery is obtained. Each claim has important deadlines, known as a statute of limitations, so it is important to review any potential claim as soon as possible.